Korro Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Net Income	-81.17	-58.03	-84.69	-26.51	-19.8	-19.17	-20.24
Depreciation & Amortization	7.24	3.91	3.84	1.58	0.81	0.65	0.53
Share-Based Compensation	2.38	1.14	21.75	9.98	3.61	0.46	0.09
Other Operating Activities	4.27	-0.66	-16.96	-30.24	48.54	1.04	5
Operating Cash Flow	-67.28	-53.65	-76.06	-45.19	34.22	-17.02	-14.61
Capital Expenditures	-7.84	-5.21	-2.91	-6.67	-1.06	-0.44	-1.86
Change in Investments	19	16.27	-63.21	17.07	-17.2	0	0
Investing Cash Flow	11.16	11.06	-66.13	10.4	-18.26	-0.44	-1.86
Share Issuance / Repurchase	154.55	0.06	1.36	41.69	80.06	0.07	0.03
Debt Issued / Paid	0	0	0	15	0	5	0
Other Financing Activities	33.21	-0.04	-	-	61.95	36.64	27.95
Financing Cash Flow	187.76	0.02	1.36	56.69	142.02	41.71	27.98
Net Cash Flow	131.64	-42.57	-140.83	21.9	157.97	24.25	11.5
Free Cash Flow	-75.12	-58.86	-78.97	-51.86	33.15	-17.46	-16.48
Free Cash Flow Margin	-	-	-561.37%	-140.22%	114.53%	-	-
Free Cash Flow Per Share	-49.12	-230.65	-114.95	-80.39	191.65	-570.51	-1172.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).